Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02885714
Other study ID # ACCURATE
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 2016
Est. completion date June 2033

Study information

Verified date October 2021
Source Turku University Hospital
Contact Anssi Ryösä, MD
Phone +35823138051
Email anssi.ryosa@tyks.fi
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Rotator cuff tear is a very common and disabling condition that can be related to acute trauma such as falling on the shoulder. A tear is associated with symptoms such as pain in abduction, abduction weakness and night pain. Rotator cuff tear surgery is a well-established form of treatment in acute rotator cuff tears, although beneficial results have been reported for both conservative and surgical treatment of rotator cuff tears. Rotator cuff tear repair surgery involves a considerable amount of re-ruptures, and it is possible that the repaired tendon do not heal despite surgical repair. On the other hand rotator cuff tears are also found in completely asymptomatic persons and the clinical significance of a rupture may be generally lower than estimated. The above-mentioned factors, as well as recent research and meta-analysis on the treatment of mainly degenerative rotator cuff tears indicate that there is a limited evidence that surgery is not more effective in treating symptomatic rotator cuff tear than conservative treatment alone. However, these previous research findings cannot be applied directly to traumatic tears, although degeneration can be considered always to contribute to the creation of a rotator cuff tear. During few last decades, despite the lack of evidence on the superiority of one treatment over another, the use of surgery to treat this disorder has been substantially increased. Treatment expectations are found to be important in predicting patient related outcome measures. In addition, surgery itself may produce a profound placebo effect. There are no previous placebo-controlled trials on the topic of interest. In order to find out the true efficacy of surgical treatment of acute, trauma related rotator cuff tears involving mainly the supraspinatus tendon, the investigators have designed this multi-centre, randomized, placebo-controlled efficacy trial.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date June 2033
Est. primary completion date June 2023
Accepts healthy volunteers No
Gender All
Age group 45 Years to 70 Years
Eligibility Inclusion Criteria: 1. Age of patient over 45 and below 70 years 2. Acute onset of shoulder symptoms after a traumatic event (any kind of sudden stretch, pull, fall, or impact, on the shoulder that is associated with the onset of symptoms) 3. Shoulder symptoms relating to rotator cuff tear = pain laterally on the shoulder and/or painful motion arc during abduction or flexion 4. MRI documented full thickness supraspinatus (ssp) tear Exclusion Criteria: 1. Traumatic event of the shoulder due a criminal act of violence with legal consequences 2. A delay of more than 4 months after the onset of symptoms of trauma to the day of intervention 3. Arthroscopically documented partial thickness rotator cuff tear only 4. A large MRI documented full thickness rotator cuff tear, sagittal tear size at the level of footprint larger than 3cm 5. MRI or arthroscopically documented total width of infraspinatus (isp) or subscapularis (ssc) tear 6. MRI or arthroscopically documented fully dislocated biceps tendon (biceps out of the groove) with concomitant subscapularis tear 7. Positive clinical rotatory lag sign (ER1 lag (>10 degrees), lift off lag (involuntary drop against the back), horn blower lag (involuntary internal rotation of the forearm in supported elevated position)) 8. Marked fatty degeneration in any of the cuff muscles (more than Fuchs/Goutallier grade 2) 9. Radiographically or MRI documented concomitant fracture line of the involved extremity or bony avulsion of the torn tendon or dislocation of the humeral head or the acromioclavicular joint. 10. Concomitant clinically detectable motoric nerve injury affecting the shoulder 11. Radiographically documented severe osteoarthritis of the glenohumeral joint, Samilson-Prieto 2 or above 12. Non-congruency of the glenohumeral joint in radiographs (Hamada stage 2 or above) 13. Clinical stiffness of the glenohumeral joint (severely limited passive range of motion: glenohumeral external rotation < 30 degrees, and abduction with stabilized scapula <60 degrees) 14. Previous surgery of the affected shoulder (affecting clavicle, scapula or upper third of the humerus) 15. Earlier sonographic or MRI finding of a rotator cuff tear 16. Previous symptoms of the ipsilateral shoulder requiring conservative treatment (glucocorticosteroid injections and/or physiotherapy) delivered by health care professionals during the last five years 17. Systemic glucocorticosteroid or antimetabolite medication during the last 5 years 18. Ongoing treatment for malignancy 19. ASA classification 3 or 4 20. Patient's inability to understand written and spoken Finnish, Norwegian or Swedish 21. History of alcoholism, drug abuse, psychological or other emotional problems likely to jeopardise informed consent 22. Patients with a contraindication/noncomplience for MRI examination or use of electrocautery devices 23. Previous randomization of the contralateral shoulder into the ACCURATE trial 24. Patient's denial for operative treatment and/or participation in the trial

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Placebo surgery and supervised specific exercises
The patient is prepared for surgery as normal (plexus+general anesthesia or TIVA, with antibiotic prophylaxis). The arthroscope is introduced in the glenohumeral joint, and thereafter online randomization is performed. The joint space is evaluated. Nothing is to be removed or excised and the use of any vapour or shaver device is not allowed. The presence of a full-thickness rotator cuff tear is verified. Altogether 3 to 5 small stab wounds are made in typical locations resembling locations of typical rotator cuff repair. The time spent in the operating theatre with patients in placebo group should resemble the time spent with patients in the active treatment group and hence give an impression of a rotator cuff repair.
Rotator cuff repair and supervised specific exercises
The patient is prepared for surgery as normal (plexus+general anesthesia or TIVA, with antibiotic prophylaxis). The arthroscope is introduced in the glenohumeral joint, and thereafter online randomization is performed. The joint space is evaluated and the presence of a full-thickness rotator cuff tear is verified. The cuff tear is repaired to its anatomic location using suture anchors according to surgeon preference. . A biceps tenotomy or tenodesis may be performed according to surgeon preference if the biceps tendon is noted to be frayed, unstable or inflamed. An additional acromioplasty may be performed according to surgeon preference.

Locations

Country Name City State
Finland Helsinki University Hospital Helsinki
Finland Central Finland Central Hospital Jyväskylä
Finland Kuopio University Hospital Kuopio
Finland Oulu University Hospital Oulu
Finland Satakunta Central Hospital Pori
Finland Hatanpää Hospital Tampere
Finland Tampere University Hospital Tampere
Finland Turku University Hospital Turku
Finland Vaasa Central Hospital Vaasa
Norway Sørlandet sykehus HF Arendal
Norway Oslo University Hospital, Ullevål Hospital Oslo
Norway Martina Hansens Hospital Sandvika
Norway St. Olafs Hospital HF Trondheim
Sweden Skånevård Sund, Region Skåne Helsingborg
Sweden Kalmar County Hospital Kalmar
Sweden Linköping University Hospital Linköping
Sweden Varberg Hospital Varberg

Sponsors (1)

Lead Sponsor Collaborator
Turku University Hospital

Countries where clinical trial is conducted

Finland,  Norway,  Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Western Ontario Rotator Cuff index (WORC) compared to baseline at two years. Patient reported disease specific outcome measure for rotator cuff conditions. The change of WORC is also compared to baseline at 3 and 6 months, 1 , 2, 5 and 10 years
Secondary Constant Score Shoulder specific outcome measure combining subjective and objective variables 3 and 6 months, 1 , 2, 5 and 10 years
Secondary Numeric rating scale of patients' shoulder pain during the last week at rest, during activity and at night. Subjective pain intensity measure. The numeric pain rating scale (pain NRS). Scale 0 to 10. 0 = no pain and 10 = worst possible pain. 3 and 6 months, 1 , 2, 5 and 10 years
Secondary 15D Generic health-related quality of life instrument 3 and 6 months, 1 , 2, 5 and 10 years
Secondary Subjective patient satisfaction Patient reported scale for treatment satisfaction 3 and 6 months, 1 , 2, 5 and 10 years
Secondary Rotator cuff integrity in MRI investigation 2, 5 and 10 years
Secondary Development of osteoarthritic signs in radiographs 2, 5 and 10 years
Secondary Development of cuff tear arthropathy in radiographs 2, 5 and 10 years